Moderate to Severe Upper Facial Lines research hub

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines

This study is testing a new medicine, IPN10200, for improving moderate to severe lines on the upper face. Researchers want to find the best dose that is both safe and works well, comparing it to an inactive treatment (placebo) and an existing treatment called Dysport.